Efficacy of exercse therapy for sarcopenia preventionin dialysis patients

Efficacy of exercse therapy for sarcopenia preventionin dialysis patients - Efficacy of exercse therapy for sarcopenia preventionin dialysis patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037460

Enrollment

Registered

2019-07-25

Start date

2019-07-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Exercise therapy with ergometer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients

Exclusion criteria

Exclusion criteria: cachectic state of malignancy progressed liver dysfunction pregnancy stage 3-4 cardiac failure active infection unable to walk

Design outcomes

Primary

Measure	Time frame
Evaluation of motor function by six-minutes walking distance and stand-up test, evaluation of activity of daily living by Barthel Index	—

Secondary

Measure	Time frame
Lean body mass and skeletal muskle mass measurements with Bioelectrical impedance analysis, and skin perfusion pressure	—

Countries

Japan

Contacts

Public ContactYasuyuki Ushiogi

fukui saiseikai hospital Blood purification center

ushiogi.yasuyuki3001@fukui.saiseikai.or.jp0776-23-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026